Bondt Albert A - OmicsDI

Show results for

Proteomics (3)
Transcriptomics (1)
Metabolomics (1)

Organisms

Alphavirus (2)
Betaherpesvirinae (2)
Brassica oleracea var. oleracea (2)
Cowpox virus (2)
Coxsackievirus (2)
Cytomegalovirus (2)
Dengue virus (2)
EFO:0001352 (2)
Filoviridae (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Human immunodeficiency virus (2)
Human immunodeficiency virus 1 (2)
Human immunodeficiency virus 2 (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus (2)
Japanese encephalitis virus group (2)
Lyssavirus rabies (2)
Monkeypox virus (2)
Nostoc sp. PCC 7120 = FACHB-418 (2)
Oropouche virus (2)
Orthopoxvirus (2)
Orthopoxvirus vaccinia (2)
Rattus (2)
Ruditapes decussatus (2)
Tick-borne encephalitis virus (2)
Viruses (2)
Homo sapiens (1)

Repository

pride (2)
biostudies-arrayexpress (1)
MassIVE (1)
MetaboLights (1)

Tissue

Blood plasma (2)
Rheumatoid arthritis disease specific synovial fluid (1)

Technology Type

Bottom-up proteomics (2)
Data-independent acquisition (2)
Mass Spectrometry (2)
Mass spectrometry (1)
Affinity purification coupled with mass spectrometry proteomics (1)

Instrument Platform

Orbitrap Exploris 480 (1)
Orbitrap Fusion Lumos (1)
Matrix-assisted laser desorption-ionisation imaging MS - (1)

Publication Date

2014 (1)
2023 (1)
2022 (1)
2025 (1)
2024 (1)

Study type

Transcription profiling by array (1)

Release Date

2014 (1)

Lab affiliation

Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands and Netherlands Proteomics Center, Utrecht, The Netherlands (1)
Biomolecular Mass Spectrometry and Proteomics,Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht 3584 CH, The Netherlands Netherlands Proteomics Center, Padualaan 8, Utrecht 3584 CH, the Netherlands (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Serum protein N-glycosylation changes in multiple myeloma

BACKGROUND: Multiple myeloma is characterized by clonal proliferation of malignant plasma cells in the bone marrow that produce monoclonal immunoglobulins. N-glycosylation changes of these monoclonal immunoglobulins have been reported in multiple myeloma, but previous studies on...

2022-04-27 | MTBLS676 | MetaboLights

AB001

Diamond-Blackfan anemia (DBA) is a congenital disorder that results predominantly from mutations in various ribosomal protein genes. In order to determine how these mutations affect the translation of specific mRNAs, we performed microarray analysis of polysomal transcripts isolated from lymphoblast...

ORGANISM(S): Homo sapiens

2014-01-30 | E-GEOD-43117 | biostudies-arrayexpress

Direct comparison of the hinge-cleaving proteases IgdE and BdpK for LC-MS based IgG1 clonal profiling

Human antibodies are heterogeneous molecules, primarily due to clonal sequence variations. Analytical techniques to assess antibody levels quantitatively, like ELISA assays, lack the power to determine abundances at the clonal level. Recently, we introduced an LC-MS-based approach that can distingui...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2023-08-17 | MSV000092676 | MassIVE

Longitudinal fluctuations in protein concentrations and higher-order structures in the plasma proteome of patients enduring a kidney transplant: two in-depth case studies

Using proteomics and complexome profiling we studied longitudinal variations in the plasma proteome of two kidney transplant recipients, prior to and after their transplantation, in comparison to two healthy controls. Their post-transplant course was complicated with several bacterial infections, re...

ORGANISM(S): Homo sapiens (Human)

2024-05-06 | PXD046550 | Pride

Multitiered proteome analysis displays the hyperpermeability of the rheumatoid synovial compartment for plasma proteins

Rheumatoid arthritis (RA) is characterized by synovial hyperplasia and cartilage/bone destruction. RA affects the synovial joints, the synovial lining and consequently the permeability of the synovium. As the latter is of central relevance for the distribution of systemically delivered therapeutics ...